Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger E-box-binding homeobox 2 (ZEB2) mRNA is the transcript encoding the ZEB2 protein, a member of the ZEB family of transcription factors (UniProt: O60315). It is a master regulator of the epithelial-mesenchymal transition (EMT), a process where epithelial cells lose polarity and gain migratory properties (PubMed: 28611535). ZEB2 is essential for neural crest development and organogenesis, and its haploinsufficiency leads to Mowat-Wilson syndrome, characterized by intellectual disability and distinct facial features (NIH: GeneReviews). In oncology, ZEB2 mRNA is often upregulated, driving metastasis and drug resistance in cancers such as breast, lung, and colorectal carcinoma (PubMed: 30217957). Therapeutic targeting of ZEB2 mRNA using antisense oligonucleotides (ASOs) or siRNAs aims to restore E-cadherin expression and inhibit tumor spread (PubMed: 25605103). Additionally, the miR-200 family of microRNAs acts as a natural antagonist to ZEB2 mRNA, and miR-200 mimics are being investigated as potential therapeutics (PubMed: 18485877).
RNA interference (RNAi), Antisense-mediated mRNA degradation, Translational repression
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger E-box-binding homeobox 2 mRNA (ZEB2 mRNA).